U.S. Commercialization - Health Technology Insights

OS Therapies, EVERSANA Commercialize OST-HER2

June 10, 2025

OS Therapies Inc., a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, has selected EVERSANA, a leading provider of global commercial services to the life

Spectral AI Raises $15Million in Debt for U.S. Commercialization

March 24, 2025

Spectral AI, Inc., a leading developer of the AI-driven DeepView System, which uses multi-spectral imaging and AI algorithms to predict burn healing potential, announced the

Categories

Tag: U.S. Commercialization

OS Therapies, EVERSANA Commercialize OST-HER2

Spectral AI Raises $15Million in Debt for U.S. Commercialization

Share With

Recent Posts

Health Technology Insights: Latest News And Innovations – Roundup 23 September 2025

AmeriPro Health Elects Larry Richardson as Board Chairman

Julius Clinical Welcomes Bassem Saleh as Chief Executive Officer

Shotsy Appoints Eric Perakslis as Chief Science Officer

LogicMark Launches Predictive Activity Metrics in Freedom Alert Max Device

Quick Links

Insights

Get in touch

Follow Us

Our Other Brands